Li, Xiang <br/><br/>
Dual VEGF/EGFR inhibition versus single targeted agent treatment in patients with metastatic colorectal cancer: a meta-analysis of randomized trials.  [electronic resource] 

 -  International journal of colorectal disease  Sep 2016 
 - 1655-6 p.  digital 
<br/><br/> Publication Type: Letter; Meta-Analysis 
<br/><br/><label>ISSN: </label>1432-1262 
<br/><br/><label>Standard No.: </label>10.1007/s00384-016-2593-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Colorectal Neoplasms--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Molecular Targeted Therapy<br/>Randomized Controlled Trials as Topic<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Withholding Treatment